Mendaera, Inc.’s Post

In our interview with Dr. Ashish K Kulkarni, CEO of Kebotix, he explained the value of AI, ML, and robotics, and materials science and chemistry in reducing carbon emissions across key sectors to help preserve the environment. He also noted the alignment between Kebotix's goals and the UAE's environmental initiatives. Watch the second part here: https://lnkd.in/dbrGNv-m

Delighted to introduce our latest innovation, Noxai - a free software application designed to support advisers, paraplanners and investment teams with their advisory portfolios. From custom factsheet production, interactive analytics, risk management and alerting, to AI generated commentaries - Noxai helps improve outcomes, save time and elevate client experience. Check out the video below 👇🏼 #portfolioassistant #noxai #collidr

During our interview with Dr. Ashish K Kulkarni, the chief executive officer of Kebotix, he provided an overview of the inception of the company. He discussed Kebotix's vision to impact the fields of artificial intelligence, machine learning, robotics, self-driving labs, and material science and chemistry. Watch the interview here: https://lnkd.in/dn5TY_59

Check out this recently discovered video of a keynote talk Umio CEO Chris Lawer gave in 2018 using an early version of our model of whole #livedexperience with health. Using examples from major Umio studies into #chronicpain and #diabeticobesity, Chris explains how a whole experience view - going beyond health - offers new pathways for health systems invention and integrated care. In it, he applues a more explicit ecological model that we no longer use. This whole experience view underpins the pivot towards “stuck lives” - transcending health and non-health conditions - that we are making in the new Umio model and Umio Realities technologies. We’ve the slides for this talk if anyone would like them. The lighting makes it hard to see them on the screen. #integratedcare #healthsystems #wholexperience #ecology #cocreation #valuecreation https://lnkd.in/eAu4znct

In the complex world of clinical trials, effective trial management technologies are vital for ensuring an efficient process from start to finish. In a recent keynote, Suvoda's Chief Architect, Andrew McVeigh, shared his insights on how setting and maintaining a clear technical direction has been key to Suvoda’s success. Discover Andrew’s 4 key factors for shaping a lasting technical direction in our latest blog post at https://lnkd.in/ea3ks6FK #Suvoda #clinicaltrials #clinicalresearch #healthtech

“By optimising for an electric fleet, operators can save time and money in their charging infrastructure as well, maximising dwell times in charging locations, and requiring lower powered chargers." — AI route optimization with Aussie start-up Adiona Tech" by Andrea Persico at Fleet HV News. 📰 With Adiona, we're reshaping logistics management by offering real-time updates and transparency to businesses seeking streamlined operations. 💡 #AdionaTech #LogisticsInnovation #RouteOptimization #FleetManagement

🚀 Embracing disruption with a purpose! At Avasant, we believe that strategic disruption guided by core principles is key to driving innovation and growth. As RJ Hazra perfectly stated, 'Disruption for the sake of disruption makes no sense. There needs to be a guiding principle, a core value, a north star.' Discover more insights on how to turn intelligent digital investments into impactful business outcomes in our latest report. https://hubs.ly/Q02G_Qqx0 #Innovation #BusinessGrowth #Avasant Avi Manik

At the Surgical Disruptive Technology Summit, The Mullings Group's Joe Mullings sat down with Proximie's CEO and Founder, Dr. Nadine Hachach-Haram FRCS (Plast), BEM and Greg Roche of Distalmotion, to discuss the critical need for trusted collaborations in the medtech industry. In this wide-ranging discussion about the principles behind Proximie's partnership with Distalmotion, the trio highlighted the following: 🤝 The reciprocity of a partnership that brings together shared learnings and expertise, that ultimately get channelled towards delivering the best patient care possible. A partnership based on an "Invent together" ethos. ⚡ The "great fit" of Proximie and Distalmotion's partnership. "Otherwise I'm hiring 50 software engineers and we're having to build the piping and infrastructure that Proximie provide. It would take us years to do that instead of days." 🌐 How the partnership enables connectivity that "literally breaks down barriers." 💡 Proximie's role as "the digital powerhouse" that can help drive great and elegant robots like Distalmotion forwards on their journey. To watch the full interview, click on the link below. #medtech #collaboration #robotics #software #cloudcomputing

I completely forgot this video of a keynote talk I gave in 2018 using an early version of my model of whole #livedexperience with health. Using examples from major Umio studies into #chronicpain and #diabeticobesity, i explain how a whole experience view - going beyond health - offers new pathways for health systems invention and integrated care. In it, I apply a more explicit ecological model that I no longer use. This whole experience view underpins the pivot towards “stuck lives” - transcending health and non-health conditions - that we are making in the new Umio model and Umio Realities technologies. I’ve got the slides for this talk if anyone would like them. The lighting makes it hard to see them on the screen. #integratedcare #healthsystems #wholeexperience #ecology #cocreation #valuecreation #healthecosystems #creation #capacities #affect #bergson #deleuze #assemblage Neal Halfon Nicki Sutton Paul Hobcraft Daniel Pesut, PhD, RN, FAAN Mark Parsonage Stephanie Hussels Paul Barnett John Odden Angela Kennedy FRSA Seonad McHugh Ife Thomas

We are excited to share a recorded conversation on trends in #VCHealthcare with Adair Newhall, Partner, featuring Kush Parmar (Managing Partner, 5AM Ventures), Peter Svennilson (Founder & Managing Partner, The Column Group), and Robert Tjian (Discovery Partner, The Column Group). In this discussion, they provide unique insights on the potential advancements and opportunities in this space fueled by the intersection of drug discovery and artificial intelligence. The full video can be found here: https://bit.ly/3D4JLhu